- recruitingPHASE4
Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
This study looks at a medicine called metreleptin for people with partial lipodystrophy. It's an open-label study, meaning everyone knows what treatment they're getting. Doctors want to see how well it works, if it's safe, and how the body reacts to it.
France · Germany · Italy - recruiting
MEASuRE: Metreleptin Effectiveness And Safety Registry
This study, called MEASuRE, is tracking the long-term effects of a medicine called metreleptin for people with rare fat-wasting conditions called lipodystrophy. It's collecting real-world information to better understand how the medicine works and its safety outside of initial trials.
United States · France · Germany